Back

RELAXIN-LA in worsening HFpEF

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: therapeutic innovations in heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Jeffrey Testani

Yale School of Medicine, New Haven (United States of America)

3 More presentations in this session

Presentation thumbnail
Effect of finerenone on the plasma proteome: a FINEARTS-HF analysis
Doctor M. Berger (Wuppertal, DE)
Slides Video
Presentation thumbnail
MRA response score in HFrEF
Professor N. Girerd (Nancy, FR)
Slides Video
Presentation thumbnail
Main 3-Year Outcomes of CASTLE-HTx
Professor P. Sommer (Bad Oeynhausen, DE)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Science: therapeutic innovations in heart failure
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Daily Subcutaneous injections of Relaxin is a therapy for heart failure with preserved ejection fraction
thumbnail
Congress Presentation
AZD3427, a novel relaxin receptor agonist and impact on renal perfusion in patients with heart failure with reduced ejection rraction: the phase 1b Re-Perfuse study design
thumbnail
Congress Presentation
Advances in medical therapy in heart failure - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources